Literature DB >> 19589900

Characterization of Shigella sonnei isolates from travel-associated cases in Japan.

Hidemasa Izumiya1, Yuki Tada2, Kenichiro Ito2, Tomoko Morita-Ishihara1, Makoto Ohnishi1, Jun Terajima1, Haruo Watanabe1.   

Abstract

Shigella sonnei infection in industrialized countries is often associated with foreign travel. A total of 195 S. sonnei isolates in Japan, isolated from cases associated with foreign travel, were analysed by biotyping and molecular typing using PFGE and multilocus variable-number tandem-repeat analysis (MLVA); their antimicrobial susceptibilities were also evaluated. The isolates were from 26 countries, most of which were Asian. Molecular typing revealed a correlation among the genotypes, biotypes and their geographical areas of origin. The isolates were classified into two biotypes, a and g. Biotype g isolates (n=178) were further divided into distinct clusters mainly on the basis of their geographical areas of origin by both PFGE and MLVA. Isolates from South Asian countries constituted one of the distinct clusters. Biotype g isolates from countries other than South Asia constituted other distinct clusters. Most of the isolates from other countries and continents, excluding the South Asian countries, were included in one major cluster by PFGE analysis. However, by MLVA, they were further divided into minor subclusters mainly on the basis of their countries of origin. MLVA was also demonstrated to be useful in molecular epidemiological analysis, even when only seven loci were applied, resulting in a high resolution with Simpson's index of diversity (D) of 0.993. A core drug-resistance pattern of streptomycin, sulfisoxazole, tetracycline and trimethoprim-sulfamethoxazole was observed in 108 isolates, irrespective of their geographical areas of origin, but the frequency of resistance to nalidixic acid was high among the South Asian and East Asian isolates. Two isolates from China and India were resistant to cefotaxime and harboured the bla(CTX-M-14) and bla(CTX-M-15) genes, respectively; these isolates were also resistant to nalidixic acid, which is a matter of concern in terms of shigellosis treatment. Use of a combination of methods was found to be effective for epidemiological investigation in the case of S. sonnei infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589900     DOI: 10.1099/jmm.0.011809-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Identification and characterization of CTX-M-producing Shigella isolates in the United States.

Authors:  Jason P Folster; Gary Pecic; Amy Krueger; Regan Rickert; Karen Burger; Alessandra Carattoli; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

2.  Characterization of Shigella sonnei in Malaysia, an increasingly prevalent etiologic agent of local shigellosis cases.

Authors:  Xiu Pei Koh; Chien Shun Chiou; Noni Ajam; Haruo Watanabe; Norazah Ahmad; Kwai Lin Thong
Journal:  BMC Infect Dis       Date:  2012-05-20       Impact factor: 3.090

3.  Laboratory based surveillance of travel-related Shigella sonnei and Shigella flexneri in Alberta from 2002 to 2007.

Authors:  Steven J Drews; Chris Lau; Marnie Andersen; Christina Ferrato; Kim Simmonds; Liala Stafford; Bev Fisher; Doug Everett; Marie Louie
Journal:  Global Health       Date:  2010-11-01       Impact factor: 4.185

4.  Diversity of Variable Number Tandem Repeat Loci in Shigella Species Isolated from Pediatric Patients.

Authors:  Reza Ranjbar; Mojtaba Memariani; Hamed Memariani
Journal:  Int J Mol Cell Med       Date:  2015

5.  Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to India.

Authors:  Niall De Lappe; Jean O'Connor; Patricia Garvey; Paul McKeown; Martin Cormican
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

6.  Drug resistance profiles and clonality of sporadic Shigella sonnei isolates in Ankara, Turkey.

Authors:  Birgul Kacmaz; Ozlem Unaldi; Nedim Sultan; Riza Durmaz
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

7.  Genetic characterization of Shigella flexneri isolates in Guizhou Province, China.

Authors:  Shijun Li; Qiangzheng Sun; Xiaoyu Wei; John D Klena; Jianping Wang; Ying Liu; Kecheng Tian; Xia Luo; Changyun Ye; Jianguo Xu; Dingming Wang; Guangpeng Tang
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

8.  Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010.

Authors:  Bing Gu; Xing Ke; Shiyang Pan; Yan Cao; Ling Zhuang; Rongbin Yu; Huimin Qian; Genyan Liu; Mingqing Tong
Journal:  J Biomed Res       Date:  2013-02-28

9.  Multilocus variable-number tandem-repeat analysis for genotyping of Shigella sonnei strains isolated from pediatric patients.

Authors:  Reza Ranjbar; Mojtaba Memariani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

10.  Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh.

Authors:  Abu I M S Ud-Din; Syeda U H Wahid; Hasan A Latif; Mohammad Shahnaij; Mahmuda Akter; Ishrat J Azmi; Trisheeta N Hasan; Dilruba Ahmed; Mohammad A Hossain; Abu S G Faruque; Shah M Faruque; Kaisar A Talukder
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.